MAM
Kajaria with Akshay Kumar echo the mood of the nation
MUMBAI: Kajaria Ceramics, India’s No. 1 tile company has just rolled out its brand campaign for 2019. A 360- degree power packed multimedia campaign led by a mega ad film starring Akshay Kumar.
Created by Crayons Communications, the campaign is the third edition of the hugely successful Kajaria brand idea “Desh Ki Mitti Se Bani Tile Se, Desh Ko Banate Hain”.
Mr. Rishi Kajaria, Joint Managing Director, Kajaria Ceramics, said: “It’s a great time for Indian brands. Our nation is growing at a rapid pace and we are growing along with it. Today, India loves and trusts ‘Made In India’ brands like Kajaria, because we have the technology and expertise to churn out products that are at par with the best in the world. This is exactly what we have captured in our brand campaign for 2019”.
Talking about the campaign Mr. Ranjan Bargotra, President, Crayons Communications, said: “This campaign is a reflection of a strong nation that is excelling on multiple fronts. It carries on with the theme of ‘Desh ki mitti’ while making it more contextual. The campaign is being launched just before Independence Day on TV, Outdoor, Digital and Print medium”.
Mr. Rondeep Gogoi, ECD, Crayons communications, said: “As love for the country grows with every success story flashing in the media, more and more brands across categories are jumping on to the ‘Proud to be Indian’ platform. What helps us stand out is that we keep our narrative simple, topical and believable. And this time it is no different”.
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
